address1,city,zip,country,phone,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,auditRisk,boardRisk,compensationRisk,shareHolderRightsRisk,overallRisk,governanceEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,quoteType,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,revenuePerShare,returnOnAssets,grossProfits,freeCashflow,operatingCashflow,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,marketState,exchange,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,regularMarketChangePercent,regularMarketPrice,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,earningsCallTimestampStart,earningsCallTimestampEnd,isEarningsDateEstimate,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,priceToBook,sourceInterval,exchangeDataDelayedBy,averageAnalystRating,cryptoTradeable,hasPrePostMarketData,firstTradeDateMilliseconds,shortName,longName,corporateActions,regularMarketTime,trailingPegRatio
ScheelevAegen 22,Lund,223 63,Sweden,46 46 16 56 70,https://www.hansabiopharma.com,Biotechnology,biotechnology,Biotechnology,Healthcare,healthcare,Healthcare,"Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe. The company offers Idefirix(imlifidase), which targets and cleaves all classes of immunoglobulin G (IgG) antibodies for the desensitization treatment of sensitized adult kidney transplant patients with a positive crossmatch test. It is also developing HNSA-5487, a next generation IgG-cleaving enzyme to address acute and chronic neuro-autoimmune conditions, including myasthenia gravis. In addition, the company evaluates imlifidase in three therapy areas, including autoimmune, gene therapy, and transplantation. It has a collaboration agreement with Sarepta Therapeutics to assess imlifidase as a pre-treatment in limb-girdle muscular dystrophy (LGMD) and duchenne muscular dystrophy (DMD); AskBio to evaluate imlifidase as a pre-treatment in pompe disease; and research and development collaboration agreement with Genethon to evaluate the safety and efficacy of imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies. Hansa Biopharma AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.",138,"[{'maxAge': 1, 'name': 'Ms. Renee  Aguiar-Lucander', 'age': 62, 'title': 'Chief Executive Officer', 'yearBorn': 1962, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. C. Evan Ballantyne', 'age': 64, 'title': 'CFO & Senior VP', 'yearBorn': 1960, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Monika  Tornsen', 'age': 46, 'title': 'COO & President of U.S.', 'yearBorn': 1978, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Eva-Maria  Joed', 'age': 55, 'title': 'Vice President of Finance & Administration', 'yearBorn': 1969, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Klaus  Sindahl', 'title': 'VP & Head of Investor Relations', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Anne Säfström Lanner', 'age': 55, 'title': 'Senior VP & Chief Human Resources Officer', 'yearBorn': 1969, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Emanuel  Björne', 'age': 51, 'title': 'VP & Head of Business Development', 'yearBorn': 1973, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Lena  Winstedt', 'age': 55, 'title': 'Head of Science', 'yearBorn': 1969, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Vincenza  Nigro M.B.A.', 'title': 'VP & Head of Medical Affairs', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Magnus  Korsgren', 'age': 55, 'title': 'VP & Head of Research and Development', 'yearBorn': 1969, 'exercisedValue': 0, 'unexercisedValue': 0}]",8,2,5,7,2,1748736000,[],86400,2,26.28,26.16,25.56,26.56,26.28,26.16,25.56,26.56,0.0,1.531,-3.5712347,221062,221062,219476,493250,493250,26.14,26.2,0,0,2172942336,19.58,57.3,11.96001,25.0064,29.3647,0.0,0.0,SEK,False,2544667136,0.0,40633615,82558600,0.09348,0.41702998,1421460,-9.198,1735603200,1767139200,1743379200,-625739008,-9.25,-7.37,14.006,-4.518,-0.44589472,0.1185931,EQUITY,26.32,143.0,32.0,95.0,110.0,2.0,buy,3,250200000,3.689,-563176512,1018134016,1.821,1.832,181684000,2.727,-0.46040002,95758000,-472900128,-637614016,0.185,0.52706003,0.0,-1.4079499,SEK,HNSA.ST,en-US,US,Equity,Delayed Quote,True,HIGH,PREPRE,STO,finmb_12485604,Europe/Stockholm,CEST,7200000,se_market,False,0.15220322,26.32,0.03999901,25.56 - 26.56,Stockholm,219476,6.74,0.3442288,19.58 - 57.3,-30.98,-0.5406632,-44.58947,1752749940,1752766200,1752766200,1745496000,1745496000,True,-9.25,-7.37,-5.68,-4.633803,1.3136005,0.052530576,-3.0447006,-0.10368574,-2.8614917,15,0,2.0 - Buy,False,False,1192604400000,Hansa Biopharma AB,Hansa Biopharma AB (publ),[],1751470189,
